outputs
LABEL_0
LABEL_1
LABEL_2
LABEL_3


0.40.20-0.20.60.810.2089610.208961base value0.01300710.0130071fLABEL_0(inputs)0.01 recent <secondary_problem>DVT</secondary_problem> who presents with <primary_sign> 0.004 hypotension</primary_sign> 0.004 and <primary_symptom>RP bleed</primary_symptom>. 0.002 966 mL Total out: 725 mL 225 mL Urine: 725 mL 225 mL NG: Stool: Drains: Balance: 2, 0.001 o male with <secondary_problem>PMH</secondary_problem> of 0.001 <secondary_problem>HTN</secondary_problem>, 0.0 <secondary_problem>MDS</secondary_problem> with recent dx <secondary_problem>adenoca</secondary_problem> of unknown primary and 0.0 o <secondary_problem>prostate ca</secondary_problem>, 0.0 031 mL 315 mL PO: 480 mL 240 mL TF: IVF: 585 mL 75 mL Blood products: 1, -0.021 (98. -0.018 Adhesive Tape (Topical) Unknown;fReview of systems is unchanged from admission except as noted below Review of systems: -0.016 [**Known lastname 1136**] and patient's preference History obtained from Patient History obtained from PatientEpinephrine induction of AF -0.015 insp/min SpO2: 93% Heart rhythm: V Paced Total In: 3, -0.013 -continue outpt regimen. . -0.01 this month - macrodantin avoided because of renal clearance, started levofloxacin for UTI, -0.01 {98/19(53) - 157/83(97)} mmHg RR: 16 (11 - 22) -0.009 3 HR: 70 (70 - 73) bpm BP: 116/46(63) -0.009 post leuk and nit; had been on suppressive macrodantin which was stopped earlier -0.008 Neurontin 400 qhs Levothyroxine Amiodarone -0.008 200 mg daily Omeprazole Simvastatin 10 mg daily -0.007 Last dose of Antibiotics: Infusions: Other ICU medications: -0.007 colaceFlowsheet Data as of [**2111-8-27** -0.007 Dexamthasone 4 mg [**Hospital1 **] -0.007 bumped appropriately to total of 4 u PRBCs and 1 u FFP -0.006 ] 07:30 AM Vital signs Hemodynamic monitoring Fluid balance 24 hours Since 12 AM Tmax: 37. -0.006 <\s><\s><problem>Hypothyroid</problem>. -0.006 1 C -0.005 . -0.005 Other medications: Oxycodone Levaquin d 2 Zofran PRN -0.004 111-8-26**] - -0.003 NC - scheduled oxycodone per Dr. -0.003 </s><problem>RP bleed</problem> [**2 -0.003 7 Tcurrent: 36.8 C -0.002 will await culture data - O2 sat remained stable on 2L -0.002 [**Known lastname 1136 -0.001 **] is an 84 y. -0.001 - K normalized with 2 doses of kayexcelate - hemodynamically stable -0.001 (in total has gotten 6 u PRBCs since first seen in ED) -0.001 Mr -0.001 . -0.001 <secondary_problem>HL</secondary_problem>, -0.001 s/p CABG, h. -0.0 (98. -0.0 - PICC line deferred because of -0.0 leukocytosis - repeat UA wiht >50 WBCs,
inputs
-0.001 / 2
Mr
-0.001
.
-0.002 / 8
[**Known lastname 1136
-0.001 / 8
**] is an 84 y.
0.001 / 9
o male with <secondary_problem>PMH</secondary_problem> of
0.001 / 6
<secondary_problem>HTN</secondary_problem>,
-0.001 / 5
<secondary_problem>HL</secondary_problem>,
-0.001 / 7
s/p CABG, h.
0.0 / 9
o <secondary_problem>prostate ca</secondary_problem>,
0.0 / 17
<secondary_problem>MDS</secondary_problem> with recent dx <secondary_problem>adenoca</secondary_problem> of unknown primary and
0.01 / 11
recent <secondary_problem>DVT</secondary_problem> who presents with <primary_sign>
0.004 / 4
hypotension</primary_sign>
0.004 / 7
and <primary_symptom>RP bleed</primary_symptom>.
-0.005 / 3
.
-0.006 / 16
<\s><\s><problem>Hypothyroid</problem>.
-0.013 / 12
-continue outpt regimen. .
-0.003 / 8
</s><problem>RP bleed</problem> [**2
-0.004 / 9
111-8-26**] -
-0.007 / 14
bumped appropriately to total of 4 u PRBCs and 1 u FFP
-0.001 / 17
(in total has gotten 6 u PRBCs since first seen in ED)
-0.001 / 17
- K normalized with 2 doses of kayexcelate - hemodynamically stable
-0.0 / 9
- PICC line deferred because of
-0.0 / 12
leukocytosis - repeat UA wiht >50 WBCs,
-0.009 / 18
post leuk and nit; had been on suppressive macrodantin which was stopped earlier
-0.01 / 20
this month - macrodantin avoided because of renal clearance, started levofloxacin for UTI,
-0.002 / 15
will await culture data - O2 sat remained stable on 2L
-0.003 / 8
NC - scheduled oxycodone per Dr.
-0.016 / 30
[**Known lastname 1136**] and patient's preference History obtained from Patient History obtained from PatientEpinephrine induction of AF
-0.018 / 29
Adhesive Tape (Topical) Unknown;fReview of systems is unchanged from admission except as noted below Review of systems:
-0.007 / 16
Last dose of Antibiotics: Infusions: Other ICU medications:
-0.005 / 21
Other medications: Oxycodone Levaquin d 2 Zofran PRN
-0.008 / 13
Neurontin 400 qhs Levothyroxine Amiodarone
-0.008 / 13
200 mg daily Omeprazole Simvastatin 10 mg daily
-0.007 / 13
Dexamthasone 4 mg [**Hospital1 **]
-0.007 / 16
colaceFlowsheet Data as of [**2111-8-27**
-0.006 / 27
] 07:30 AM Vital signs Hemodynamic monitoring Fluid balance 24 hours Since 12 AM Tmax: 37.
-0.006 / 2
1 C
-0.0 / 3
(98.
-0.003 / 9
7 Tcurrent: 36.8 C
-0.021 / 3
(98.
-0.009 / 20
3 HR: 70 (70 - 73) bpm BP: 116/46(63)
-0.01 / 24
{98/19(53) - 157/83(97)} mmHg RR: 16 (11 - 22)
-0.015 / 24
insp/min SpO2: 93% Heart rhythm: V Paced Total In: 3,
0.0 / 34
031 mL 315 mL PO: 480 mL 240 mL TF: IVF: 585 mL 75 mL Blood products: 1,
0.002 / 41
966 mL Total out: 725 mL 225 mL Urine: 725 mL 225 mL NG: Stool: Drains: Balance: 2,
0.0
306
0.0
mL
0.0
0.0
90
0.0
mL
0.0
0.0
Respiratory
0.0
support
0.0
0.0
O
0.0
2
0.0
D
0.0
elivery
0.0
Device
0.0
:
0.0
N
0.0
asal
0.0
cannula
0.0
0.0
SpO
0.0
2
0.0
:
0.0
93
0.0
%
0.0
AB
0.0
G
0.0
:
0.0
0.0
//
0.0
/
0.0
25
0.0
/
0.0
GEN
0.0
:
0.0
nad
0.0
0.0
He
0.0
ent
0.0
:
0.0
EO
0.0
MI
0.0
,
0.0
o
0.0
/
0.0
p
0.0
clear
0.0
0.0
CV
0.0
:
0.0
R
0.0
RR
0.0
,
0.0
no
0.0
m
0.0
/
0.0
r
0.0
/
0.0
g
0.0
0.0
P
0.0
ul
0.0
m
0.0
:
0.0
CTA
0.0
b
0.0
/
0.0
l
0.0
0.0
Abd
0.0
:
0.0
soft
0.0
,
0.0
NT
0.0
,
0.0
ND
0.0
,
0.0
bowel
0.0
sounds
0.0
present
0.0
0.0
Ext
0.0
:
0.0
+
0.0
tr
0.0
ace
0.0
edema
0.0
b
0.0
/
0.0
l
0.0
157
0.0
K
0.0
/
0.0
u
0.0
L
0.0
0.0
9
0.0
.
0.0
8
0.0
g
0.0
/
0.0
dL
0.0
0.0
139
0.0
mg
0.0
/
0.0
dL
0.0
0.0
1
0.0
.
0.0
5
0.0
mg
0.0
/
0.0
dL
0.0
0.0
25
0.0
mEq
0.0
/
0.0
L
0.0
0.0
4
0.0
.
0.0
5
0.0
mEq
0.0
/
0.0
L
0.0
0.0
48
0.0
mg
0.0
/
0.0
dL
0.0
0.0
102
0.0
mEq
0.0
/
0.0
L
0.0
0.0
137
0.0
mEq
0.0
/
0.0
L
0.0
0.0
27
0.0
.
0.0
5
0.0
%
0.0
0.0
22
0.0
.
0.0
7
0.0
K
0.0
/
0.0
u
0.0
L
0.0
WBC
0.0
0.0
19
0.0
.
0.0
6
0.0
0.0
23
0.0
.
0.0
0
0.0
0.0
22
0.0
.
0.0
7
0.0
0.0
H
0.0
ct
0.0
0.0
24
0.0
.
0.0
8
0.0
0.0
23
0.0
.
0.0
6
0.0
0.0
19
0.0
.
0.0
4
0.0
0.0
18
0.0
.
0.0
6
0.0
0.0
31
0.0
.
0.0
3
0.0
0.0
31
0.0
.
0.0
5
0.0
0.0
24
0.0
.
0.0
7
0.0
0.0
28
0.0
.
0.0
0
0.0
0.0
27
0.0
.
0.0
5
0.0
0.0
Pl
0.0
t
0.0
0.0
259
0.0
0.0
168
0.0
0.0
157
0.0
0.0
Cr
0.0
0.0
1
0.0
.
0.0
3
0.0
0.0
1
0.0
.
0.0
7
0.0
0.0
1
0.0
.
0.0
7
0.0
0.0
1
0.0
.
0.0
6
0.0
0.0
0
0.0
.
0.0
5
0.0
0.0
1
0.0
.
0.0
5
0.0
0.0
T
0.0
rop
0.0
T
0.0
0.0
0
0.0
.
0.0
05
0.0
0.0
0
0.0
.
0.0
05
0.0
0.0
Glucose
0.0
0.0
162
0.0
0.0
139
0.0
0.0
Other
0.0
labs
0.0
:
0.0
PT
0.0
/
0.0
PTT
0.0
/
0.0
INR
0.0
:
0.0
12
0.0
.
0.0
4
0.0
/
0.0
25
0.0
.
0.0
0
0.0
/
0.0
1
0.0
.
0.0
0
0.0
,
0.0
CK
0.0
/
0.0
CK
0.0
MB
0.0
/
0.0
0.0
Tro
0.0
ponin
0.0
-
0.0
T
0.0
:
0.0
244
0.0
/
0.0
5
0.0
/
0.0
0
0.0
.
0.0
05
0.0
,
0.0
ALT
0.0
/
0.0
AST
0.0
:
0.0
48
0.0
/
0.0
39
0.0
,
0.0
Alk
0.0
Ph
0.0
os
0.0
/
0.0
T
0.0
B
0.0
ili
0.0
:
0.0
69
0.0
/
0.0
1
0.0
.
0.0
0
0.0
,
0.0
0.0
Differential
0.0
-
0.0
Ne
0.0
uts
0.0
:
0.0
93
0.0
.
0.0
6
0.0
%,
0.0
Lymph
0.0
:
0.0
3
0.0
.
0.0
4
0.0
%,
0.0
Mono
0.0
:
0.0
2
0.0
.
0.0
8
0.0
%,
0.0
E
0.0
os
0.0
:
0.0
0
0.0
.
0.0
1
0.0
%,
0.0
0.0
Fib
0.0
rin
0.0
ogen
0.0
:
0.0
254
0.0
mg
0.0
/
0.0
dL
0.0
,
0.0
L
0.0
actic
0.0
Acid
0.0
:
0.0
2
0.0
.
0.0
0
0.0
mmol
0.0
/
0.0
L
0.0
,
0.0
Al
0.0
bumin
0.0
:
0.0
2
0.0
.
0.0
9
0.0
g
0.0
/
0.0
dL
0.0
,
0.0
LDH
0.0
:
0.0
385
0.0
0.0
IU
0.0
/
0.0
L
0.0
,
0.0
Ca
0.0
++
0.0
:
0.0
7
0.0
.
0.0
1
0.0
mg
0.0
/
0.0
dL
0.0
,
0.0
Mg
0.0
++
0.0
:
0.0
2
0.0
.
0.0
2
0.0
mg
0.0
/
0.0
dL
0.0
,
0.0
PO
0.0
4
0.0
:
0.0
5
0.0
.
0.0
2
0.0
mg
0.0
/
0.0
dL
0.0